The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Starikova N.L.

Vagner Perm State Medical University

Kulesh A.A.

Vagner Perm State Medical University

Familial hemiplegic migraine

Authors:

Starikova N.L., Kulesh A.A.

More about the authors

Read: 10143 times


To cite this article:

Starikova NL, Kulesh AA. Familial hemiplegic migraine. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(7):114‑117. (In Russ.)
https://doi.org/10.17116/jnevro2021121071114

Recommended articles:
The rela­tionship of diet and nutrition with the frequency of migraine atta­cks. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):30-35
Biochemical features of migraine pathogenesis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):21-26
Recu­rrent pain syndromes in adolescents of different ages. Russian Journal of Pain. 2025;(2):24-31
Prophylactic treatment of migraine in real clinical practice. Russian Journal of Pain. 2025;(2):63-69
Biofeedback in complex therapy of pain syndromes. Russian Journal of Pain. 2025;(2):70-75

References:

  1. Thomsen LL, Kirchmann Eriksen M, Faerch Romer S, Andersen I, Ostergaard E, Keidling N, Olesen J, Russell MB. An epidemiological survey of hemiplegic migraine. Cephalalgia. 2002;22(5):361-375.  https://doi.org/10.1046/j.1468-2982.2002.00371.x
  2. Sutherland HG, Albury CL, Griffiths LR. Advances in genetics of migraine. J Headache Pain. 2019;20:72.  https://doi.org/10.1186/s10194-019-1017-9
  3. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.  https://doi.org/10.1177/0333102417738202
  4. Thomsen LL, Olesen J. Sporadic hemiplegic migraine. Cephalalgia. 2004;24:1016-1023. https://doi.org/10.1111/j.1468-2982.2004.00788.x
  5. Hiekkala ME, Vuola P, Artto V, Häppölä P, Häppölä E, Vepsäläinen S, Cuenca-León E, Lal D, Gormley P, Hämäläinen E, Ilmavirta M, Nissilä M, Säkö E, Sumelahti ML, Harno H, Havanka H, Keski-Säntti P, Färkkilä M, Palotie A, Wessman M, Kaunisto MA, Kallela M. The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: a clinical and genetic study in Finnish migraine families. Cephalalgia. 2018;38(12):1849-1863. https://doi.org/10.1177/0333102418761041
  6. Maksemous N, Smith RA, Sutherland HG, Maher BH, Ibrahim O, Nicholson GA, Carpenter EP, Lea RA, Cader MZ, Griffiths LR. Targeted next generation sequencing identifies a genetic spectrum of DNA variants in patients with hemiplegic migraine. Cephalalgia Reports. 2019;2:1-9.  https://doi.org/10.1177/2515816319881630
  7. Pelzer N, Haan J, Stam AH, Vijfhuizen LS, Koelewijn SC, Smagge A, de Vries B, Ferrari MD, van den Maagdenberg AMJM, Terwindt GM. Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation. Neurology. 2018;90(7):575-582.  https://doi.org/10.1212/WNL.0000000000004966
  8. Eising E, de Vries B, Ferrari MD, Terwindt GM, van den Maagdenberg A. Pearls and pitfalls in genetic studies of migraine. Cephalalgia. 2013;33(8):614-625.  https://doi.org/10.1177/0333102413484988
  9. Hansen JM, Hauge AW, Ashina M, Olesen J. Trigger factors for familial hemiplegic migraine. Cephalalgia. 2011;31(12):1274-1281. https://doi.org/10.1177/0333102411415878
  10. Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011;10(5):457-470.  https://doi.org/10.1016/S1474-4422(11)70048-5.
  11. Pelzer N, Hoogeveen E, Ferrari MD, Poll-The BT, Kruit MC, Terwindt GM. Brain atrophy following hemiplegic migraine attacks. Cephalalgia. 2018;38(6):1199-1202. https://doi.org/10.1177/0333102417723569
  12. Cha Y-H, Millett D, Kane M, Jen J, Baloh R. Adult-onset hemiplegic migraine with cortical enhancement and oedema. Cephalalgia. 2007;27(10):1166-1170. https://doi.org/10.1111/j.1468-2982.2007.01369.x
  13. Schubert V, Auffenberg E, Biscup S, Jurkat-Rott K, Freilinger T. Two novel families with hemiplegic migraine caused by recurrent SCN1A mutation p.FI 499L. Cephalalgia. 2018;38(8):1503-1508. https://doi.org/10.1177/0333102417742365
  14. Roth C, Freilinger T, Kirovski G, Dunkel J, Shah Y, Wilken B, Rautenstrauß B, Ferbert A. Clinical spectrum in three families with familial hemiplegic migraine type 2 including a novel mutation in the ATP I A2 gene. Cephalalgia. 2014;34(3):183-190.  https://doi.org/10.1177/0333102413506128
  15. Pelzer N, Stam AH, Carpay JA, de Vries B, van den Maagdenberg AMJM, Ferrari MD, Haan J, Terwindt GM. Familial hemiplegic migraine treated by sodium valproate and lamotrigine. Cephalalgia. 2014;34(9):708-711.  https://doi.org/10.1177/0333102413520086
  16. Indelicato E, Nachbauer W, Eigentler A, Donnemiller E, Wagner M, Unterberger I, Boesch S. Ten years of follow-up in a large family with familial hemiplegic migraine type 1: clinical course and implications for treatment. Cephalalgia. 2018;38(6):1167-1176. https://doi.org/10.1177/0333102417715229
  17. Topakian R, Pischinger B, Stieglbauer K, Pichler R. Rare clinical findings in a patient with sporadic hemiplegic migraine: FDG-PET provides diminished brain metabolism at 10-year follow-up. Cephalalgia. 2014;34(5):392-396.  https://doi.org/10.1177/0333102413513182

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.